Neuromodulation Devices Market: 2020 Worldwide Opportunities
The global neuromodulation devices market size is projected to reach USD 9.34 billion by 2026, exhibiting a CAGR of 9.5% during the forecast period. Steady climb in the prevalence of chronic conditions across the globe will be a key factor fueling the growth of this market, observes Fortune Business Insights™ in its report, titled “Neuromodulation Devices Market Size, Share & Industry Analysis, By Product Type (Spinal Cord Stimulators (SCS), Deep Brain Stimulators (DBS), Vagus Nerve Stimulators (VNS), Sacral Nerve Stimulators (SNS)
Please visit: https://www.fortunebusinessinsights.com/industry-reports/neuromodulation-devices-market-100561
Detailed Table of Content:
- Introduction
1.1. Research Scope
1.2. Market Segmentation
1.3. Research Methodology
1.4. Definitions and Assumptions
- Executive Summary
- Market Dynamics
3.1. Market Trends
3.2. Market Drivers
3.3. Market Restraints
3.4. Market Opportunities
- Key Insights
4.1. Prevalence of Key Disease Indications, Key Countries/ Region
4.2. Technology Advances, Non-invasive Devices
4.3. Recent Product Approvals, Key Regions
4.4. Key Developments: Mergers, Acquisitions, Partnerships, etc.
- Global Neuromodulation Devices Market Analysis, Insights and Forecast, 2015-2026
5.1. Key Findings / Summary
5.2. Market Analysis, Insights and Forecast – By Product Type
5.2.1. Spinal Cord Stimulators
5.2.2. Deep Brain Stimulators
5.2.3. Vagus Nerve Stimulators
5.2.4. Sacral Nerve Stimulators
5.2.5. Transcranial Magnetic Stimulators
5.2.6. Others
5.3. Market Analysis, Insights and Forecast – By Type
5.3.1. Invasive
5.3.2. Non-invasive
5.4. Market Analysis, Insights and Forecast – By Application
5.4.1. Pain Management
5.4.2. Neurological Disorders
5.4.3. Respiratory Disorders
5.4.4. Others
5.5. Market Analysis, Insights and Forecast – By End User
5.5.1. Hospitals
5.5.2. Specialty Clinics
5.6. Market Analysis, Insights and Forecast – By Region
5.6.1. North America
5.6.2. Europe
5.6.3. Asia Pacific
5.6.4. Latin America
5.6.5. Middle East & Africa
- North America Neuromodulation Devices Market Analysis, Insights and Forecast, 2015-2026
6.1. Key Findings / Summary
6.2. Market Analysis, Insights and Forecast – By Product Type
6.2.1. Spinal Cord Stimulators
6.2.2. Deep Brain Stimulators
6.2.3. Vagus Nerve Stimulators
6.2.4. Sacral Nerve Stimulators
6.2.5. Transcranial Magnetic Stimulators
6.2.6. Others
6.3. Market Analysis, Insights and Forecast – By Type
6.3.1. Invasive
6.3.2. Non-invasive
6.4. Market Analysis, Insights and Forecast – By Application
6.4.1. Pain Management
6.4.2. Neurological Disorders
6.4.3. Respiratory Disorders
6.4.4. Others
6.5. Market Analysis, Insights and Forecast – By End User
6.5.1. Hospitals
6.5.2. Specialty Clinics
6.6. Market Analysis, Insights and Forecast – By Country
6.6.1. U.S.
6.6.2. Canada
- Europe Neuromodulation Devices Market Analysis, Insights and Forecast, 2015-2026
7.1. Key Findings / Summary
7.2. Market Analysis, Insights and Forecast – By Product Type
7.2.1. Spinal Cord Stimulators
7.2.2. Deep Brain Stimulators
7.2.3. Vagus Nerve Stimulators
7.2.4. Sacral Nerve Stimulators
7.2.5. Transcranial Magnetic Stimulators
7.2.6. Others
7.3. Market Analysis, Insights and Forecast – By Type
7.3.1. Invasive
7.3.2. Non-invasive
7.4. Market Analysis, Insights and Forecast – By Application
7.4.1. Pain Management
7.4.2. Neurological Disorders
7.4.3. Respiratory Disorders
7.4.4. Others
7.5. Market Analysis, Insights and Forecast – By End User
7.5.1. Hospitals
7.5.2. Specialty Clinics
7.6. Market Analysis, Insights and Forecast – By Country/ Sub-region
7.6.1. U.K.
7.6.2. Germany
7.6.3. France
7.6.4. Spain
7.6.5. Italy
7.6.6. Scandinavia
7.6.7. Rest of Europe
- Asia Pacific Neuromodulation Devices Market Analysis, Insights and Forecast, 2015-2026
8.1. Key Findings / Summary
8.2. Market Analysis, Insights and Forecast – By Product Type
8.2.1. Spinal Cord Stimulators
8.2.2. Deep Brain Stimulators
8.2.3. Vagus Nerve Stimulators
8.2.4. Sacral Nerve Stimulators
8.2.5. Transcranial Magnetic Stimulators
8.2.6. Others
8.3. Market Analysis, Insights and Forecast – By Type
8.3.1. Invasive
8.3.2. Non-invasive
8.4. Market Analysis, Insights and Forecast – By Application
8.4.1. Pain Management
8.4.2. Neurological Disorders
8.4.3. Respiratory Disorders
8.4.4. Others
8.5. Market Analysis, Insights and Forecast – By End User
8.5.1. Hospitals
8.5.2. Specialty Clinics
8.6. Market Analysis, Insights and Forecast – By Country/ Sub-region
8.6.1. Japan
8.6.2. China
8.6.3. India
8.6.4. Australia
8.6.5. Southeast Asia
8.6.6. Rest of Asia Pacific
Continued...